Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-11

Clinical Trial Update: Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients [Phase 3]

View source ↗

Summary

Phase III clinical trial update for Azvudine in treatment-naive HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azvudine (azvudine)

Snippet

Sponsor: Henan Genuine Biotech Co., Ltd. | Conditions: HIV-infection/Aids | Phase 3 | Status: UNKNOWN